Laboratorio Reig Jofre S A : Appointment of the new Chief Financial Officer (CFO)
December 20, 2023 at 02:49 am EST
Share
Appointment of the new Chief Financial Officer (CFO)
20 December 2023
REIG JOFRE, a pharmaceutical company listed on the continuous market of the Spanish stock exchange appoints Laura Martí as its new Chief Financial Officer (CFO).
Laura Martí holds a degree in Business Sciences from the Universitat Rovira i Virgili in Tarragona (Spain). Furthermore, she completed an international program in Business Administration at Clemson University in South Carolina, United States. Her education was further enhanced with a Global Executive MBA from the IESE Business School in Barcelona.
With over 20 years leading the financial direction at the renowned multinational corporation General Electric, Laura has held key roles in various industrial sectors within GE, including energy and healthcare. Her expertise covers different geographical locations, encompassing the United States, Switzerland, France, the United Kingdom, Italy, Brazil, and Mexico.
Over the past two years, following her return to Barcelona, Laura joined the publicly listed company on the continuous market, Audax Renovables, serving as the Group's Global CFO.
Her international and multifunctional leadership, combined with her experience in capital markets, has been centered around defining and implementing high-impact business and financial strategies, specializing in global-scale operations, services, and digital technology.
With this appointment, REIG JOFRE reaffirms its commitment to consolidating the company's presence and positioning in the stock market while continuing to generate value through financial and strategic excellence. Moreover, it aims to further drive business success by fostering innovation, enhancing operational efficiency, and promoting collaborative leadership with a specific focus on sustainable and profitable long-term international growth.
Laboratorio Reig Jofre SA published this content on 20 December 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 December 2023 07:48:34 UTC.
Laboratorio Reig Jofre SA, formerly Natraceutical SA, is a Spain-based company primarily engaged in the research, development, manufacturing and marketing of drugs. The Companyâs activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The Company also provides nutritional cosmetics, and food supplements, among others. It operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.
LABORATORIO REIG JOFRE, S.A. 
